Eleva
Eleva is a clinical-stage biopharmaceutical company that develops complex biologics using a proprietary moss-based technology platform. The company focuses on creating therapies for complement disorders, such as Factor H (CPV-104), and chronic retinal diseases like Age-related Macular Degeneration (AMD). Its pipeline includes two innovative therapies currently in clinical development aimed at patients with previously inaccessible therapeutic needs.
Biotechnology
Pharmaceuticals
Healthcare
Funding summary
- Total raised
- €60.0M
- Funding rounds
- 1
Investors in Eleva
Investors on record for Eleva. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Eleva?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors